Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats

European Journal of Pharmacology

Volumn 378, Issue 1, 1999, Pages 23-30

  Hashimoto, Shinji ^a   Inoue, Takeshi ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

5 HT (hydroxytryptamine, serotonin); Citalopram; Conditioned fear stress; Freezing behavior; Medial prefrontal cortex; Microdialysis, in vivo

Indexed keywords

CITALOPRAM; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONDITIONING; CONTROLLED STUDY; FEAR; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CITALOPRAM; CONDITIONING (PSYCHOLOGY); FEAR; MALE; MICRODIALYSIS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STRESS; SYNAPTIC TRANSMISSION;

EID: 0032812809     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00441-0     Document Type: Article

References (39)

1. Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol. Sci. 14:1993;262.
2. Blanchard R.J., Blanchard D.C. Crouching as an index of fear. J. Comp. Physiol. Psychol. 67:1969;370-375.
3. Bolles R.C. Species-specific defense reactions and avoidance learning. Psychol. Rev. 77:1970;32-48.
4. Bolles R.C., Collier A.C. The effect of predictive cues on freezing in rats. Anim. Learn. Behav. 4:1976;6-8.
5. Bouton M.E., Bolles R.C. Conditioned fear assessed by freezing and by the suppression of three different baselines. Anim. Learn. Behav. 8:1980;429-434.
6. Boyer W.F. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta analysis. Int. Clin. Psychopharmacol. 10:1995;45-49.
7. Boyer W.F., Feighner J.P. A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder. Int. Clin. Psychopharmacol. 8:1993;173-176.
8. Cutler N.R., Sramek J.J., Wardle T.S., Hesselink J.M., Roeschen J.K. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial. Psychopharmacol. Bull. 29:1993;303-308.
9. Den Boer J.A., Westenberg H.G.M. Effect of serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline. Int. Clin. Psychopharmacol. 3:1988;59-74.
10. Dubovsky S.L. Generalized anxiety disorder: new concepts and psychopharmacologic therapies. J. Clin. Psychiatry. 51:1990;3-10. Suppl.
11. Eriksson, E., Humble, M., 1990. Serotonin in psychiatric pathophysiology: a review of data from experimental and clinical research. In: Pohl, R., Gershon, S. (Eds.), Progress in Basic Clinical Pharmacology, Vol. 3. The Biological Basis of Psychiatric Treatment. Karger, Basel, pp. 66-119.
12. Fanselow M.S., Helmstetter F.J. Conditional analgesia, defensive freezing, and benzodiazepines. Behav. Neurosci. 102:1988;233-243.
13. Gorman J.M. The use of newer antidepressants for panic disorder. J. Clin. Psychiatry. 58:1997;54-58. Suppl. 14.
14. Gunasekara N.S., Noble S., Benfield P. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs. 55:1998;85-120.
15. Handley S.L., Mc Blane J.W. 5HT drugs in animal models of anxiety. Psychopharmacology. 112:1993;13-20.
16. Hashimoto S., Inoue T., Koyama T. Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology. 123:1996;182-186.
17. 1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior. Pharmacol. Biochem. Behav. 58:1997;471-475.
18. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60:1993;776-779.
19. Hjorth S. (-)Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur. J. Pharmacol. 303:1996;183-186.
20. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260:1994;251-255.
21. Hyttel J. Citalopram: pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry. 6:1982;277-295.
22. Inoue T., Koyama T., Yamashita I. Effect of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacol. Biochem. Behav. 44:1993;371-374.
23. Inoue T., Tsuchiya K., Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol. Biochem. Behav. 49:1994;911-920.
24. Inoue T., Tsuchiya K., Koyama T. Serotonergic activation reduced defensive freezing in the conditioned fear paradigm. Pharmacol. Biochem. Behav. 53:1996;825-831.
25. 1A receptors. Eur. J. Pharmacol. 260:1994;243-246.
26. Iversen S.D. 5-HT and anxiety. Neuropharmacology. 23:1984;1553-1560.
27. Kahn R.S., van Praag H.M., Wetzler S., Asnis G.M., Barr G. Serotonin and anxiety revisited. Biol. Psychiatry. 23:1988;189-208.
28. Kalin N.H., Sherman J.E., Takahashi L.K. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res. 457:1988;130-135.
29. Lott M., Greist J.H., Jefferson J.W., Kobak K.A., Katzelnick D.J., Katz R.J., Schaettle S.C. Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study. J. Clin. Psychopharmacol. 17:1997;255-260.
30. Oehrberg S., Christiansen P.E., Behnke K., Borup A.L., Severin B., Soegaard J., Calberg H., Judge R., Ohrstrom J.K., Manniche P.M. Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. Br. J. Psychiatry. 167:1995;374-379.
31. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, NY.
32. Rex A., Marsden C.A., Fink H. Effect of diazepam on cortical 5-HT release and behavior in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology. 110:1993;490-496.
33. Schneier F.R., Goetz D., Campeas R., Fallon B., Marshall R., Liebowitz M.T. Placebo-controlled trial of moclobemide in social phobia. Br. J. Psychiatry. 172:1998;70-77.
34. Sharp T., Bramwell S.R., Clark D., Grahame-Smith D.G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: change in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 53:1989;234-240.
35. Stefanski R., Goldberg S.R. Serotonin 5-HT2 receptor antagonist: potential in the treatment of psychiatric disorders. CNS Drugs. 7:1997;388-409.
36. Tiller J.W., Bouwer C., Behnke K. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder. Int. Clin. Psychopharmacol. 12:1997;S27-30. Suppl. 6.
37. Van der Kolk B.A., Dreyfuss D., Michaels M., Shera D., Berkowitz R., Fisler R., Saxe G. Fluoxetine in posttraumatic stress disorder. J. Clin. Psychiatry. 55:1994;517-522.
38. Van Vliet I.M., Den Boer J.A., Westenberg H.G. Psychopharmacological treatment of social phobia: a double blind placebo controlled study with fluvoxamine. Psychopharmacology. 115:1994;128-134.
39. Wise C.D., Berger B.D., Stein L. Anxiety-reducing activity by reduction of serotonin turnover in the brain. Science. 177:1972;180-183.